KEROS THERAPEUTICS INC's ticker is KROS and the CUSIP is 492327101. A total of 83 filers reported holding KEROS THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $240,611 | -48.5% | 5,265 | -25.5% | 0.00% | – |
| Q1 2024 | $467,570 | +81.2% | 7,063 | +8.8% | 0.00% | – |
| Q4 2023 | $258,003 | +24.3% | 6,489 | -0.4% | 0.00% | – |
| Q3 2023 | $207,603 | -21.9% | 6,512 | -1.5% | 0.00% | – |
| Q2 2023 | $265,670 | +5.9% | 6,612 | +12.5% | 0.00% | – |
| Q1 2023 | $250,948 | -16.7% | 5,877 | -6.4% | 0.00% | – |
| Q4 2022 | $301,422 | +36.4% | 6,277 | +99.9% | 0.00% | – |
| Q4 2020 | $221,000 | – | 3,140 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fairmount Funds Management LLC | 292,833 | $17,134,000 | 5.65% |
| Deep Track Capital, LP | 1,300,000 | $76,063,000 | 5.37% |
| Octagon Capital Advisors LP | 340,214 | $19,906,000 | 3.87% |
| Opaleye Management Inc. | 265,750 | $15,549,000 | 3.30% |
| First Light Asset Management, LLC | 552,098 | $32,303,000 | 2.31% |
| Altium Capital Management LP | 116,000 | $6,787,000 | 1.87% |
| Nantahala Capital Management | 796,698 | $46,615,000 | 1.64% |
| Orbimed Advisors | 1,679,417 | $98,263,000 | 1.26% |
| Darwin Global Management, Ltd. | 111,500 | $6,524,000 | 1.00% |
| Parkman Healthcare Partners LLC | 69,861 | $4,088,000 | 0.90% |